SATOF yields 3.11% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SATOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SATOF + PFE for your $10,000?
Sato Holdings Corporation engages in the manufacture and sale of labeling products in Japan and internationally. It offers printers, consumables, cloud-based preventative maintenance solution, hand labelers, stickers and primary labels, primary package consulting, radio frequency identification tags, troubleshooting assistance, and maintenance services. The company also provides various solutions, such as hardware, consumables, maintenance services and software, demonstrating ROI, and other services; SATO online services, a cloud-based monitoring services for printers that enable preventive maintenance and on-the-spot troubleshooting; and develops application software and enables integration with ERP, WMS, and MDM systems. It serves retail, manufacturing, food, logistics, health care, postal, government/municipal offices, utilities, education, and public transit industries. Sato Holdings Corporation was founded in 1940 and is headquartered in Tokyo, Japan.
Full SATOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.